DS-2741a / Daiichi Sankyo  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DS-2741a / Daiichi Sankyo
NCT04211415: Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

Terminated
1
8
Japan
DS-2741a, Placebo
Daiichi Sankyo Co., Ltd.
Atopic Dermatitis
03/20
12/20

Download Options